Clinical Trial Update: Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluates the effectiveness, safety, and tolerability of Duac Akne Gel and Epiduo Gel in treating facial acne vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Duac Akne Gel (benzoyl peroxide 5% / clindamycin phosphate 1%)
• Epiduo Gel (adapalene 0.1% / benzoyl peroxide 2.5%)

Snippet

Sponsor: Stiefel, a GSK Company | Conditions: Acne Vulgaris | Phase 4 | Status: COMPLETED